ArriVent BioPharma Statistics
Total Valuation
AVBP has a market cap or net worth of $897.36 million. The enterprise value is $614.71 million.
| Market Cap | 897.36M |
| Enterprise Value | 614.71M |
Important Dates
The next estimated earnings date is Sunday, February 2, 2025, before market open.
| Earnings Date | Feb 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AVBP has 33.70 million shares outstanding. The number of shares has increased by 1,230.98% in one year.
| Current Share Class | 33.70M |
| Shares Outstanding | 33.70M |
| Shares Change (YoY) | +1,230.98% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 2.65% |
| Owned by Institutions (%) | 47.81% |
| Float | 15.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.23 |
| P/TBV Ratio | 3.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.28, with a Debt / Equity ratio of 0.00.
| Current Ratio | 19.28 |
| Quick Ratio | 18.69 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.07% and return on invested capital (ROIC) is -26.05%.
| Return on Equity (ROE) | -36.07% |
| Return on Assets (ROA) | -24.68% |
| Return on Capital (ROIC) | -26.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.03M |
| Employee Count | 40 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 29.25 |
| 200-Day Moving Average | 22.72 |
| Relative Strength Index (RSI) | 44.10 |
| Average Volume (20 Days) | 156,987 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -93.72M |
| Pretax Income | n/a |
| Net Income | -81.05M |
| EBITDA | n/a |
| EBIT | -93.72M |
| Earnings Per Share (EPS) | -$3.42 |
Balance Sheet
The company has $282.86 million in cash and $213,000 in debt, giving a net cash position of $282.64 million or $8.39 per share.
| Cash & Cash Equivalents | 282.86M |
| Total Debt | 213,000 |
| Net Cash | 282.64M |
| Net Cash Per Share | $8.39 |
| Equity (Book Value) | 277.49M |
| Book Value Per Share | 8.24 |
| Working Capital | 277.24M |
Cash Flow
| Operating Cash Flow | -68.97M |
| Capital Expenditures | n/a |
| Free Cash Flow | -68.97M |
| FCF Per Share | -$2.05 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVBP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,230.98% |
| Shareholder Yield | -1,230.98% |
| Earnings Yield | -9.03% |
| FCF Yield | -7.69% |
Analyst Forecast
The average price target for AVBP is $36.80, which is 38.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $36.80 |
| Price Target Difference | 38.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |